Drug intelligence / Profile preview

GO365

Development stage
Unknown
Lead developer
Charak
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

GO365 is a comprehensive joint care product line developed by Charak, formulated to support joint and cartilage health, reduce inflammation, and alleviate joint and muscle pain. The product range includes GO365 Nutra Tablets, GO365 Ointment, GO365 Spray, and the GO365 Joint Care Kit. GO365 Nutra Tablets are oral nutraceutical supplements containing a synergistic blend of glucosamine hydrochloride, chondroitin sulfate, calcium carbonate, vitamins (C, D3, E), and Ayurvedic herbs like turmeric (Curcuma longa) and Boswellia serrata, which work internally to prevent cartilage degradation and promote joint lubrication. GO365 Ointment and Spray are topical Ayurvedic formulations containing active herbal ingredients such as capsicum oil, camphor, menthol, wintergreen oil, and eucalyptus oil, which act as counter-irritants and anti-inflammatory agents to provide rapid relief from joint stiffness, sprains, and muscular pain.

Brand names
GO365GO-365GO 365GO365 Joint Care ComboGO-365 Joint Care ComboGO 365 Joint Care ComboGO365 Joint Care KitGO-365 Joint Care KitGO 365 Joint Care KitGO365 NutraGO-365 NutraGO 365 NutraGO365 Nutra TabletsGO-365 Nutra TabletsGO 365 Nutra TabletsGO365 OintmentGO-365 OintmentGO 365 OintmentGO365 SprayGO-365 SprayGO 365 Spray
Other names
Go 365Go365Go-365
02

Targets

ALOX5 (Arachidonate 5-lipoxygenase)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TRPM8 (Transient receptor potential cation channel subfamily M member 8)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on GO365.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GO365.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call